Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from DSS ( (DSS) ) is now available.
On February 4, 2026, DSS, Inc. priced a firm-commitment underwritten public offering of 900,000 shares of common stock at $1.00 per share, with gross proceeds expected to be about $1.0 million and net proceeds of roughly $0.7 million after fees and expenses. The New York-listed conglomerate, which operates in packaging, biotech, commercial lending, and investment management, said the transaction—conducted under an effective shelf registration and closed on or about February 5, 2026—will bolster general corporate and working capital needs, and included a 45-day over-allotment option for 135,000 additional shares alongside a 45-day lock-up agreement for executives and directors, underscoring both its near-term liquidity focus and capital markets engagement.
More about DSS
DSS, Inc. is a multinational company listed on the NYSE American that operates across several business lines, including product packaging, biotechnology, commercial lending, and securities and investment management, pursuing a model of developing high-growth subsidiaries and unlocking value through strategic IPOs and public listings.
Average Trading Volume: 88,862
Technical Sentiment Signal: Strong Sell
Current Market Cap: $8.55M
See more data about DSS stock on TipRanks’ Stock Analysis page.